Thyroid Health Status of Ammonium Perchlorate Workers: A Cross-Sectional Occupational Health Study
Authors:
- Lewis E. BravermanLBLewis E. Braverman
- Feng Xiao LiFLFeng Xiao Li
- Kent RichmanKRKent Richman
- Sam PinoSPSam Pino
- Gregory HowearthGHGregory Howearth
- 1 April 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 41 (4) , 248-260
Abstract
Since pharmaceutical exposures to perchlorate are known to suppress thyroid function in patients with hyperthyroidism, a study of employees at a perchlorate manufacturing plant was conducted to assess whether occupational exposure to perchlorate suppresses thyroid function. Exposure to perchlorate was assessed by measurement of ambient air concentrations of total and respirable perchlorate particles, and systemic absorption was assessed by measurement of urinary perchlorate excretion. Airborne exposures ranged from 0.004 to 167 mg total particulate perchlorate per day. Urinary perchlorate measurements demonstrated that exposure to the airborne particulate perchlorate resulted in systemic absorption. Workers were grouped into four exposure categories with mean absorbed perchlorate dosages of 1, 4, 11 and 34 mg perchlorate per day. Thyroid function was assessed by measurement of serum thyroid-stimulating hormone, free thyroxine index, thyroxine, triiodothyronine, thyroid hormone binding ratio, thyroid peroxidase antibodies, and by clinical examination. No differences in thyroid-function parameters were found between the four groups of workers across approximately three orders of magnitude of exposure and of dose. Thus human thyroid function was not affected by these levels of absorbed perchlorate. In addition, no clinical evidence of thyroid abnormalities was found in any exposure group. The blood-cell counts were normal in all groups, indicating no evidence of hematotoxicity in this exposure range. The absence of evidence of an effect on thyroid function or blood cells from occupational airborne perchlorate exposure at a mean absorption of 34 mg/day demonstrates a no-observed-adverse-effect-level (NOAEL) that can assist in the evaluation of human health risks from environmental perchlorate contamination.Keywords
This publication has 14 references indexed in Scilit:
- Thyrotropin and Thyroglobulin as an Index of Optimal Iodine Intake: Correlation with Iodine Excretion of 39,913 Euthyroid PatientsThyroid®, 1997
- Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued.Heart, 1994
- Early adaptation of thyrotropin and thyroglobulin secretion to experimentally decreased iodine supply in manMetabolism, 1992
- Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment.BMJ, 1989
- Short Term Administration of Potassium Perchlorate Restores Euthyroidism in Amiodarone Iodine-Induced Hypothyroidism*The Journal of Clinical Endocrinology & Metabolism, 1986
- Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazoleJournal of Endocrinological Investigation, 1986
- A wilcoxon‐type test for trendStatistics in Medicine, 1985
- Similar Effects of Thionamide Drugs and Perchlorate on Thyroid-Stimulating Immunoglobulins in Graves' Disease: Evidence against an Immunosuppressive Action of Thionamide DrugsThe Journal of Clinical Endocrinology & Metabolism, 1984
- Influence of Perchlorate on the Secretion of Non‐Thyroxine Iodine by the Normal Human Thyroid GlandEuropean Journal of Clinical Investigation, 1974
- Zur Pharmakologie der PerchloratwirkungNaunyn-Schmiedeberg's Archives of Pharmacology, 1929